Anoctamin-1 (ANO1) and Paired Box Gene 8 (PAX8) as Emerging Immunohistochemical Biomarkers in Endocervical Adenocarcinoma

Authors

  • Raafat Awad Hegazy, Wafaa Mohamed El Gohary, Enas Mohamed Foad, Aya Reda Samy Abd El Samad Author

DOI:

https://doi.org/10.48047/1e9jv941

Keywords:

ANO1, PAX8, Endocervical Adenocarcinoma

Abstract

Background:  Endocervical adenocarcinoma represents a heterogeneous group of malignancies with diverse etiopathogenetic mechanisms, morphological features, and clinical behaviors. Accurate diagnosis remains challenging, particularly in distinguishing primary endocervical  adenocarcinoma from metastatic adenocarcinomas involving

Downloads

Download data is not yet available.

References

WHO Classification of Tumours Editorial Board. Female Genital Tumours. 5th ed. International Agency for Research on Cancer; 2020.

Stolnicu S, Barsan I, Hoang L, et al. International Endocervical Adenocarcinoma Criteria and Classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol. 2018;42(2):214-226.

Downloads

Published

2024-11-20

How to Cite

Anoctamin-1 (ANO1) and Paired Box Gene 8 (PAX8) as Emerging Immunohistochemical Biomarkers in Endocervical Adenocarcinoma (Raafat Awad Hegazy, Wafaa Mohamed El Gohary, Enas Mohamed Foad, Aya Reda Samy Abd El Samad , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 7543-7553. https://doi.org/10.48047/1e9jv941